In vivo action of 15-lipoxygenase in early stages of human atherogenesis

Journal of Clinical Investigation

Volumn 99, Issue 5, 1997, Pages 888-893

  Kühn, Hartmut ^a   Heydeck, Dagmar ^a   Hugou, Isabelle ^a   Gniwotta, Christina ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

eicosanoids; enantiomer separation; HPLC; hydroxy fatty acids; lipid peroxidation

Indexed keywords

ARACHIDONATE 15 LIPOXYGENASE; CORIOLIC ACID; LINOLEIC ACID; LOW DENSITY LIPOPROTEIN;

ADULT; AGED; ARTICLE; ATHEROGENESIS; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; LIPID OXIDATION; MALE; PRIORITY JOURNAL;

EID: 0344145871     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI119253     Document Type: Article

References (36)

1. Ross, R. 1993. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature (Lond.). 362:801-809.
2. Steinberg, D., and J.L. Witztum. 1990. Lipoproteins and atherogenesis. JAMA (J. Am. Med. Assoc.). 264:3047-3052.
3. Steinberg, D., S. Parthasarathy, T.E., Carew, J.C. Khoo, and J.L. Witztum. 1989. Beyond cholesterol. Modification of low density lipoprotein that increase its atherogenicity. N. Engl. J. Med J. 320:915-924.
4. Takano, T., and C. Mineo. 1990. Atherosclerosis and molecular pathology: Mechanism of cholesterol ester accumulation in foam cells and extracellular space of atherosclerotic lesions. J. Pharmacobiodyn. 13:385-413.
5. Aqel, N.M., R.Y. Ball, H. Waldman, and M.J. Mitchinson. 1984. Monocyte origin of foam cells in human atherosclerotic plaques. Atherosclerosis 53: 265-271.
6. Amanuma, K., T. Kanaseki, S. Ikeuchi, S. Ohkuma, and T. Takano. 1986. Studies on fine structure and location of lipids in quick-freeze replicas of atherosclerotic aorta in WHHL rabbits. Virchows Arch. 410:231-238.
7. Ylä-Hertluala, S., W. Palinski, M.E. Rosenfeld. S. Parthasarathy, T.E. Carew, S. Butler, J.L. Wiztum, and D. Steinberg. 1989. Evidence for the presence of oxidatively modified low density lipoprotein in atherosclerotic lesions of rabbit and man. J. Clin. Invest. 84:1086-1059.
8. Holvoet, P., and C. Collen. 1994. Oxidized lipoproteins in atherosclerosis and thrombosis. FASEB J. 8:1284-1297.
9. Esterbauer, H., and P. Ramos. 1995. Chemistry and Pathophysiology of oxidation of LDL. Rev. Physiol. Biochem. Pharmacol. 127:31-34.
10. Ylä-Herttuala, S., M.E. Rosenfeld, S. Parthasarathy, C.K. Glass, E. Sigal, T. Sarkioia, J.T. Witztum, and D. Steinberg. 1991. Gene expression in macrophage rich human atherosclerotic lesions. J. Clin. Invest. 87:1146-1152.
11. Ylä-Herttuala, S., M.E. Rosenfeld, S. Parthasarathy, C.K. Glass, E. Sigal, J.T., Witztum, and D. Steinberg. 1990. Colocalization of 15-lipoxygenase mRNA and protein with epitopes of oxidized low density lipoprotein in macrophage-rich areas of atherosclerotic lesions. Proc. Natl. Acad. Sci. USA. 87: 6959-6936.
12. 2 mimics cell-mediated oxidative modification. J. Lipid Res. 29:745-753.
13. Cathcart, M.K., A.K. McNally, G.M. Chisolm. 1991. Lipoxygenase mediated transformation of human low density lipoprotein to an oxidized and cytotoxic complex. J. Lipid Res. 32:63-70.
14. Belkner, J., R. Wiesner, J. Rathman, J. Barnett, E. Sigal, and H. Kühn. 1993. Oxygenation of lipoproteins by mammalian lipoxygenases. Eur. J. BioChem. 213:251-261.
15. Kühn, H., J. Belkner, S. Zaiss, T. Fährenklemper, and S. Wohlfeil. 1994. Involvement of 15-lipoxygenase in early stages of atherogenesis. J. Exp. Med. 179:1903-1911.
16. Harland, W.A., J.D. Gilbert, G. Steel, and J.W. Brooks. 1971. Lipids of human atheroma. Atherosclerosis. 13:239-246.
17. Kühn, H., J. Belkner, R. Wiesner, T. Schewe, V.Z. Lankin, and A.K. Tikhaze. 1992. Structure elucidation of oxygenated lipids in human atherosclerotic lesions. Eicosanoids. 5:17-22.
18. Harland, W.A., J.D. Gilbert, and C.J. Brooks. 1973. Lipids of human atheroma. VIII. Oxidised derivatives of cholesteryl linoleate. Biochim. Biophys. Acta. 316:378-385.
19. Folcik, V.A., R.A. Nivar-Aristy, L.P. Krajewski, and M.K. Cathcardt. 1995. Lipoxygenase contributes to the oxidation of lipids in human atherosclerotic plaques. J. Clin. Invest. 96:504-510.
20. Wissler, R. 1994. New insights into the pathogenesis of atherosclerosis as revealed bv PDAY. Atherosclerosis. 108:S3-S20.
21. Redgrave, T.G., D.C.K. Roberts, and C.E. West. 1975. Separation of plasma lipoproteins by density-gradient ultracentrifugation. Anal. Biochem. 65: 42-29.
22. Lass, A., J. Belkner, H. Esterbauer, and H. Kühn. 1996. Lipoxygenase treatment renders low density lipoprotein susceptible to copper catalyzed oxidation. Biochem. J. 314:577-585.
23. Bligh, E.G., and W.J. Dyer. 1959. A rapid method of total lipid extraction and purification. Can. J. Biochem. Biophysiol. 37:911-917.
24. Schnurr, K., J. Belkner, F. Ursini, T. Schewe, and H. Kühn. 1996. The selenoenzyme phospholipid hydroperoxide glutathione peroxidase controls the activity of the 15-lipoxygenase with complex substrates and preserves the specificity of the oxygenation products. J. Biol. Chem. 271:4653-4658.
25. Rao, S.I., A. Wilks, M. Hamberg, and P.R. Ortiz de Montellano. 1994. The lipoxygenase activity of myoglobin. J. Biol. Chem. 269:7210-7216.
26. Hugou, I., P. Blin, J. Henri, D. Daret, and J. Larrue. 1995. 15-lipoxygenase expression in smooth muscle cells from atherosclerotic rabbit aorta. Atherosclerosis. 113:189-195.
27. Conrad, D.J., H. Kühn, M. Mulkins, E. Highland, and E. Sigal. 1992. Specific inflammatory cytokines regulate the expression of human monocyte 15-lipoxygenase. Proc. Natl. Acad. Sci. USA. 89:217-221.
28. Ylä-Herttuala, S., J. Luoma, H. Viita, T. Hiltunen, and T. Nikkari T. 1995. Transfer of 15-lipoxygenase gene into rabbit iliac arteries results in the appearence of oxidation-specific lipid protein adducts characteristic of oxidized low density lipoprotein J. Clin. Invest 95:2692-2698.
29. Cornicelli, J.A., S. Sendobry, T. Bocan, K. Welch, B. Tail, B.K. Trivedi, N. Colbry, and S. Feinmark. 1995. A novel 15-lipoxygenase inhibitor lacking antioxidative properties prevents atherosclerosis in cholesterol fed rabbits. XII International Symposium on Drugs Effecting Lipid Metabolism. Nov. 7-10. 54 (Abstr.).
30. Benz, D.J., M. Mol, M. Ezaki, N. Mori-Ito, I. Zelan, A. Miyanohara, T. Friedman, S. Parthasarathy, D. Steinberg, and J.L. Witztum. 1995. Enhanced levels of lipopreoxides in low density lipoprotein incubated with murine fibroblast expressing high levels of human 15-lipoxygenase. J. Biol. Chem. 270:5191-5197.
31. Kühn, H., L. Chan. 1997. The role of 15-lipoxygenase in atherogenesis. Pro-and/or anti-atherogenic action. Curr. Opin. Lipidol. In press.
32. Shen, J., E. Herderick, F. Cornhill, E. Zsigmond. H.S. Kim, H. Kühn, N.V. Guevara, L. Chan. 1996 Macrophage-mediated 15-lipoxygernase expression protects against atherosclerosis development. J. Clin. Invest. 98:2201-2208.
33. Simon, T.C., A.N. Makheja, and J.M. Bailey. 1989. The induced lipoxygenase in atherosclerotic aorta converts linoleic acid to the platelet chemorepellant factor 13-HODE. Thromb. Res. 55:171-178.
34. Shen, J., H. Kühn, A. Petho-Schramm, and L. Chan. 1995. Transgenic rabbits with the integrated human 15-lipoxygenase gene driven by a lysozyme promotor: macrophage-specific expression and variable positional specificity of the transgenic enzyme. FASEB J. 9:1623-1631.
35. Wiesner, R., and H. Kühn. 1993. High performance liquid chromatography of oxygenated polyenoic fatty acids including enantiomer separation. In CRC-Handbook of Chromatography: Analysis of Lipids. K.D. Mukherjee and N. Weber, editors. CRC Press, Inc., Boca Raton, FL. 89-100.
36. Kühn, H. 1997. Biosynthesis, metabolization and biological importance of the primary 15-lipoxygenase metabolites 15-hydro(pero)xy-5Z.8Z,11Z,13E-eicosatetraenoic acid and 13-hydro(pero)xy-9Z,11E-octadecadienoic acid. Prog. Lipid. Res. 35:203-206.